Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Claudio Mencacci,1 Guido Di Sciascio,2 Pablo Katz,3 Claudio Ripellino31Ospedale Fatebenefratelli, Milan, Italy; 2Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy; 3CSD Medical Research Srl, Milan, ItalyBackground: Depression has a lifetime prevalence of 10%–25...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dove Medical Press
2013-02-01
|
| Ráidu: | ClinicoEconomics and Outcomes Research |
| Liŋkkat: | http://www.dovepress.com/cost-effectiveness-evaluation-of-escitalopram-in-major-depressive-diso-a12150 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|